FRANKFURT (dpa-AFX) - A negative analyst comment weighed on the Compugroup Medical share price on Wednesday. The shares of the software provider for healthcare facilities lost two percent to 33.18 euros, but have so far avoided slipping below the 32-euro mark to a low since November 2022.

Analyst Martin Jungfleisch from Exane BNP lowered the rating for the shares from "Outperform" to "Neutral". The price target, which was lowered from 49 to 36 euros, no longer justifies an optimistic vote. For the first time since July 2022, the expert no longer advised overweighting the shares in the portfolio./bek/jha/